Your comfort and adherence matterstopping the medication without guidance is unnecessary when management strategies work
In this study of adults living with overweight or obesity: Average weight loss was around 1314% Compared to around 2% with placebo With consistent adherence, weight loss increased to approximately 16.6% In addition: Around 76% of participants achieved at least 5% weight loss Around 56% achieved at least 10% weight loss Notably, around 1 in 3 patients achieved 20% or more weight loss These are significant results, but they need to be interpreted carefully
Similar to Wegovy coverage is limited to states that include obesity-indicated GLP-1s and, more recently, to its sleep apnea indication in some states
Patients who increase their dose slowlyfollowing PlexusDx personalized protocolsoften experience milder or shorter-duration diarrhea than those on faster dose schedules
Patients curious about it should hear from a physician about what is actually known and what is not
Second, real medications compounded or not will always require a prescription